Team tracks antibiotic resistance from swine farms to groundwater

The routine use of antibiotics in swine production can have unintended consequences, with antibiotic resistance genes sometimes leaking from waste lagoons into groundwater.

In a new study, researchers at the University of Illinois report that some genes found in hog waste lagoons are transferred – “like batons” – from one bacterial species to another. The researchers found that this migration across species and into new environments sometimes dilutes – and sometimes amplifies – genes conferring antibiotic resistance.

The new report, in the August issue of Applied and Environmental Microbiology, tracks the passage of tetracycline resistance genes from hog waste lagoons into groundwater wells at two Illinois swine facilities.

This is the first study to take a broad sample of tetracycline resistance genes in a landscape dominated by hog farming, said principal investigator R.I. Mackie. And it is one of the first to survey the genes directly rather than focusing on the organisms that host them. Mackie is a professor in the department of animal sciences and an affiliate of the Institute for Genomic Biology.

“At this stage, we’re not really concerned about who’s got these genes,” Mackie said. “If the genes are there, potentially they can get into the right organism at the right time and confer resistance to an antibiotic that’s being used to treat disease.”

Tetracycline is widely used in swine production. It is injected into the animals to treat or prevent disease, and is often used as an additive in hog feed to boost the animals’ growth. Its near-continuous use in some hog farms promotes the evolution of tetracycline-resistant strains in the animals’ digestive tracts and manure.

The migration of antibiotic resistance from animal feeding operations into groundwater has broad implications for human and ecological health. There are roughly 238,000 animal feeding operations in the U.S., which collectively generate about 500 million tons of manure per year. Groundwater comprises about 40 percent of the public water supply, and more than 97 percent of the drinking water used in rural areas.

Federal law mandates that animal facilities develop nutrient management plans to protect surface water and groundwater from fecal contamination. Most swine facilities hold the effluent in large, water-filled lagoons until it can be injected into the ground as fertilizer. Thanks to a change in the law in the late 1990s, new lagoons must be built with liners to prevent seepage. Swine facilities in operation prior to the new regulations are allowed to continue using unlined lagoons, however.

Some of these lagoons leak.

The researchers extracted bacterial DNA from lagoons and groundwater wells at two study sites over a period of three years. They screened these samples for seven different tetracycline resistance genes.

They found fluctuating levels of every one of the seven genes for which they screened in the lagoons. They also found that these genes were migrating from the lagoons to some of the groundwater wells.

It should be noted that many genes that confer antibiotic resistance occur naturally in the environment. Tetracycline is itself a bacterial product, employed by Streptomyces bacteria long before humans discovered its usefulness.

In order to determine the origin of the tetracycline resistance genes found in the groundwater, the researchers conducted a genetic analysis of one gene family, tet(W), in samples from the lagoons and from groundwater wells below (downgradient of) and above (upgradient to) the lagoons. They found that the variants of tet(W) genes in the upgradient, environmental control wells were distinct from those of the lagoons, while the wells downgradient of the lagoons contained genes consistent with both the background levels and those in the lagoons.

“There’s a human impact on these sites that is superimposed on a natural signal,” said postdoctoral research assistant Anthony Yannarell, an author on the study.

One of the two hog farms, “Site A,” was more impacted by resistance genes from the lagoon, due to its hydrogeology. The site included two layers of sand – at about two meters and eight meters below the surface – through which groundwater flowed.

“Every time we looked in the lagoon, we saw all of the genes we were looking for,” Yannarell said. “At Site A, all the wells that were closest to the lagoon almost always had every gene. As you got further from the lagoon you started to see genes dropping out.”

The resistance genes were present at much higher levels – “an order of magnitude higher,” said the authors – in the lagoon than in the contaminated wells. Most were diluted as they moved away from the lagoons in the groundwater.

There was one notable exception. A gene known as tet(C) was found at higher levels in some of the groundwater wells at Site A than in the lagoon. Its heightened presence was not consistent with background levels, indicating that something in the environment was amplifying this one gene, which had originated in the lagoon.

Perhaps the gene had migrated to a new organism, Yannarell said, to find a host that was more suited to conditions in the groundwater.

“What we are seeing is that the genes can travel a lot further than the bacteria,” Mackie said. “It’s a matter of getting the DNA into the right organism. It’s a relay race.”

Source: University of Illinois at Urbana-Champaign

Related stories:

Scientists identify genetic link that may neutralize HIV
Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This new information will likely spur a new approach for making an HIV vaccine that elicits neutralizing antibodies. Neutralizing antibodies, once produced in the host, can attack and checkmate an infecting virus. The research was reported in the September 5 issue of Science.
Variation of normal protein could be key to resistance to common cancer drug
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.
Researchers develop drought-tolerant corn
At the end of the day, drought tolerance in corn has to equate to good yields and good quality, not just good looks, said a Texas AgriLife Research scientist.
Rapid test for pathogens developed by K-State researchers
Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.
Scientists uncover molecule that keeps pathogens like salmonella in check
Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick.
Joslin study identifies protein that produces 'good' fat
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.
Tracking a crop disease could save millions of lives
Scientists have discovered why one of the world's most important agricultural diseases emerged, according to research published in the September issue of the Journal of General Virology. Maize streak virus (MSV) causes the main virus disease of Africa's most important food crop. By comparing the genome of the virus to those of its less harmful relatives, scientists have discovered how and why MSV became a serious pest and spread so rapidly across Africa.
DOE JGI Director highlights the genomics of plant-based biofuels in the journal Nature
Genomics is accelerating improvements for converting plant biomass into biofuel—as an alternative to fossil fuel for the nation's transportation needs, reports Eddy Rubin, Director of the U.S. Department of Energy Joint Genome Institute (DOE JGI), in the August 14 edition of the journal Nature. In "Genomics of cellulosic biofuels," Rubin lays out a path forward for how emerging genomic technologies will contribute to a substantially different biofuels future as compared to the present corn-based ethanol industry—and in part mitigate the food-versus-fuel debate.

News discussion:

Antibiotics... what a joke! in General Science news